MS&L appoints Peter Harris, Renee Wilson as new directors

Share this article:
MS&L has appointed Peter Harris to director of its corporate practice in North America, and Renee Wilson to managing director of its New York office.

In his newly created position, Harris will work with MS&L's other corporate practice directors to drive corporate strategy, leverage the agency's brand positioning, and expand the company's offerings. Part of Harris's focus, according to Sara Donaldson, a spokesperson for MS&L, will be on corporate health opportunities as they relate to reputational management, corporate social responsibility and product responsibility. “Peter's corporate practice provides reputation management and stakeholder relations support to several pharma companies, working closely with our national healthcare practice,” said Donaldson.

As managing director of MS&L's largest office, Wilson will work closely with Jim Tsokanos, president, North America, to manage client relationships and business development. Wilson will also oversee the New York office's 200 employees, and will be working more closely with the New York healthcare leaders and clients on strategic communications and innovative programs in this space, according to Donaldson. 
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?